Anti-CD20 monoclonal antibody in multiple sclerosis therapy: the results of phase 3 clinical studies on relapsing and primary progressive multiple sclerosis
2016 ◽
Vol 387
(10023)
◽
pp. 1075-1084
◽
2019 ◽
Vol 30
◽
pp. 236-243
◽
2017 ◽
Vol 23
(12)
◽
pp. 1636-1641
◽